James Moon

Company: EVOQ Therapeutics, University of Michigan

Job title: Co-Founder & Chief Scientific Officer, Professor of Pharmaceutical Sciences

Seminars:

A Novel NanoDisc Platform for Induction of Antigen-Specific Immune Tolerance 12:00 pm

Examine how subcutaneous administration of NanoDisc targets multiple lymphoid tissues and immune system organs Discover how NanoDisc carrying autoantigens induce antigen-specific T-Regs and Tr1 cells, while reducing autoreactive IgG response Learn how NanoDisc therapy exerts robust efficacy in preclinical models of Multiple Sclerosis and Type 1 DiabetesRead more

day: Day One